Introduction
Preeclampsia is an idiopathic multisystem disorder specific to human pregnancy 1 . It is defined as the onset of hypertension and the presence of proteinuria during pregnancy, usually occurring after the 20 th week of gestation in a previously normotensive woman and resolving completely by the sixth week after delivery of fetus 2 .
Preeclampsia is a transient but potentially dangerous complication of pregnancy. Generally, the incidence of preeclampsia is in the range of 4-8% of all pregnancies 3 . The incidence of preeclampsia has fallen in developed countries due to improved antenatal care, but it's incidence is still high in the developing countries 4 , and preeclampsia accounts for about 20-80% of the maternal mortality in developing countries 5 . Preeclampsia and eclampsia cause about 16 % of maternal death in Bangladesh 4 .
Despite of preeclampsia's prevalence and severity, the pathophysiology of this multisystem disorder is still poorly understood and it's etiology has not yet been fully elucidated. Environmental and nutritional factors may play a role in the development of preeclampsia 6 . The epidemiology of preeclampsia, being more common in poor women, long ago suggested that nutrients might be involved in the disorder 7 . It is Preeclampsia is the most common medical complication of pregnancy associated with increased maternal and infant mortality and morbidity. Reduced serum magnesium level is found to be associated with elevated blood pressure in preeclampsia. The purpose of this cross-sectional study is to evaluate the serum magnesium level in preeclamptic women. For this study 50 preeclamptic patients, with age range 20 to 40 years having gestational age range from 20 to 40 weeks and 50 age and gestational age matched normotensive pregnant women having no proteinuria were enrolled. Serum magnesium was measured by colorimetric method. The mean(±SD) age and mean(±SD) gestational age of preeclampsia was not significantly different from those of normotensive pregnant women (p=0.203 and p=0.251 respectively). The mean(±SD) body mass index of the preeclamptic patients was significantly higher compared to that of normotensive pregnant women (p<0.001). The mean(±SD) serum magnesium level was 3.37±2.05 mg/dl in preeclamptic group and 2.87±1.38 mg/dl in normal pregnant women; the level did not differ significantly between the subject of preeclampsia and normal pregnant women (p=0.153). Findings of this study suggest that serum magnesium has no association with preeclampsia.
Key Words: Preeclampsia, Magnesium assumed that deficiency of several essential micronutrients may be a predisposing factor in the development of preeclampsia because nutrients can modulate oxidative stress by increasing or decreasing free radicals or antioxidant and providing substrates for formation of free radicals 4 . Nutritional deficiencies are commonly found in pregnant women and it is well established that the pregnant women from developing countries usually consume diets that are low in minerals and vitamins 8 .
Magnesium is the second most abundant intracellular cation and the fourth most abundant cation in the body 9 . Magnesium is an essential cofactor for many enzyme systems. It also plays an important role in neurochemical transmission and peripheral vasodilation 10 . Some studies have reported that reduction in serum level of magnesium during pregnancy might be possible contributors in etiology and pathogenesis of preeclampsia and supplementation of this element to diet may be of value to prevent preeclampsia 11 .
Several studies observed significantly low serum magnesium level in preeclamptic women as compared to normal pregnant (p<0.05) [12] [13] [14] [15] [16] . But many studies reported that serum levels of magnesium did not differ significantly between preeclamptic and non preeclamptic groups 17, 18 . Serum magnesium level was significantly lower in preeclamptic women compared to normal pregnant women in a study in Dhaka, Bangladesh 21 . This is not enough to reach valid conclusion. So, this study was conducted to estimate the serum magnesium level in preeclampsia and normal pregnancy and to find out association between serum magnesium and preeclampsia.
Materials and Methods
This cross-sectional study was carried out in the Department of Biochemistry, Sylhet MAG Osmani Medical College in collaboration with the Department of Obstetrics and Gynaecology, Sylhet MAG Osmani Medical College Hospital during the period from January 2016 to December 2016. Fifty preeclamptic patients, with age range of 20 to 40 years having gestational age range from 20 to 40 weeks (group-A) and 50 age-and gestational agematched normotensive pregnant women having no proteinuria (group-B were enrolled in the study. Informed written consent was taken from each of the patient or legal guardian and an approval of study protocol was obtained from the ethical committee of Sylhet MAG Osmani Medical College prior to the commencement of the study. All primi pregnant women having essential hypertension, systemic or endocrine disorders, malabsorption syndrome, and patients on magnesium supplementation were excluded. Detailed history about present pregnancy regarding preeclampsia and other known disorders were taken. Gestational age was determined based on last menstrual date and confirmed by ultrasound examination. Data were collected from the selected subjects on variables of interest using a semistructured questionnaire by interview, observation, clinical examination, investigation and from the history. Blood pressure was measured in supine position or sitting position. Urine was tested for gross proteinuria (heat coagulation test). The preeclamptic patients were diagnosed by the presence of persistent hypertension (more than 140/90 mm of Hg), gross proteinuria (tested by heat coagulation test of urine), and pathological edema. Maternal weight was recorded in kilograms with the subject standing on the weight machine without shoes and minimum clothing. Maternal height was recorded with the subject barefooted, feet together, back against the upright bar of the height scale, head upright in Frankfort horizontal plane-look straight ahead. The height measuring equipment consists of a vertical bar with a horizontal bar of wood which was brought down on examinee's head. Body mass index (BMI) was calculated by the formula (BMI=Weight in kilogram/Height in meter 2 ).
Five ml of venous blood was collected from antecubital vein under aseptic precaution in a metal-free sterile tube without any anticoagulant. Test tube was coded for identification of sample. The sample was kept at room temperature for about 20-25 minutes to allow it to clot and was sent to the Department of Biochemistry, Sylhet MAG Osmani Medical College, Sylhet where serum magnesium was measured by colorimetric method.
Data were analyzed with the help of Statistical Package for Social Science (SPSS) Version21. Quantitative data was expressed as mean(±SD) (standard deviation) and unpaired Student's 't' test was done to see the level of significance. Qualitative data were expressed as frequency and percentage. The p-value of <0.05 was considered statistically significant.
Results
The mean(±SD) age was 26.70±5.59 years in preeclamptic Group-A and 25.32±5.17 years in normotensive pregnant women Group-B; the difference was not statistically significant (p=0.203) as shown in Figure- been reported that reduction in serum level of Mg during pregnancy might be a possible contributor in etiology of preeclampsia (PE), and supplementation of these minerals to diet may be of value to prevent PE 18 .
In this study the mean(±SD) age in preeclamptics and normal pregnant women did not differ significantly (p=0.203). In the current study the mean(±SD) serum magnesium level was 3.3±2.05 mg/dl in preeclampsia and 2.87±1.38 mg/dl in normal pregnant women. The mean serum magnesium level did not differ significantly between the subjects of preeclampsia and normal pregnant women (p=0.153). This result was supported by different studies 6, 12, 20 who also found no significant difference between the plasma magnesium of the patients and controls. But several other studies 8, 14, [21] [22] [23] showed that there was significantly lower serum magnesium in preeclampsia than that of normal pregnancy. Recently Dickinson et al. 24 in a meta analysis of 12 randomized trials with follow-up ranging from 8 to 26 weeks showed that causal association between magnesium supplementation and BP reduction was weak. A dose-response pattern was found in another meta-analysis with twenty studies who reported that magnesium intake only resulted in a small overall reduction in BP 25 .
The limitations of the present study are that small sample size and samples were taken from a single tertiary care Government Hospital where people of all socioeconomic status may not attend. Literature review revealed conflicting findings about serum magnesium in preeclamptic women. Like many other studies our study also showed that serum magnesium has no association in occurrence of preeclampsia. However further multicentre study involving large sample size to solve this conflicting issue is recommeded.
